The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More
Source link
Beacon Building Products to Host 2025 Investment Day Via Investing.com
HERNDON, Va.–(BUSINESS WIRE)–Beacon (Nasdaq: BECN) the leading publicly-traded specialty wholesale distributor of roofing, waterproofing and related outdoor products announced today that it will host the an Investor Day in New…